Prevalence of diabetic retinopathy in children and young people living with diabetes: protocol for a systematic review. Issue 11 (15th November 2017)

• Record Type: Journal Article
• Authors: Ibanez-Bruron, Maria Carolina; Solebo, Ameenat L; Cumberland, Phillippa M; Rahi, Jugnoo S
• Is Part Of: BMJ open. Volume 7:Issue 11(2017)
• Publication Date: 2017-11-15
• Subjects: diabetic retinopathy -- epidemiology -- paediatric ophthalmology -- preventive medicine; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2017-018578
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: The frequency of diabetes mellitus in childhood is increasing. Thus, more children and young people are at risk of developing diabetic retinopathy and diabetes related visual impairment. However, there is no consensus on optimal screening strategies for the paediatric population reflecting the lack of clarity about the current burden of disease in this group. We aim to estimate the prevalence of diabetic retinopathy in children and young people living with types 1 or 2 diabetes, and to investigate potential sources of heterogeneity in this figure so as to inform screening strategies for this population. Methods and analysis: PubMed and EMBASE will be searched from 1995 to 2016 using the OvidSP platform with no language restriction. Additionally, manual review of the references lists of included articles will be conducted. Two investigators will independently screen titles and abstracts for potential eligibility. Studies which report prevalence of diabetic retinopathy among general populations of children and young people with types 1 or 2 diabetes will be included. Pooled prevalence estimates of diabetic retinopathy reported in studies with sample size greater than 200 participants will be calculated by the random effect model. Forest plots will be used to summarise individual and pooled estimates of the prevalence. Heterogeneity between studies will be assessed using the I 2 statistic and explored through meta-regressions and subgroup analyses if the necessary data are available. Ethics and dissemination: Ethics approval is not required as this is a review of anonymised published data. We will report the findings of this systematic review in a peer-reviewed journal, and share it with the relevant professionals including health authorities through our Diabetic Eye disease in Childhood Study collaborative network. Clinical trail registration: PROSPERO (CRD42017067178 ).